Soleus Capital Amends C4 Therapeutics Stake as of Dec 31, 2023

TL;DR

**Soleus Capital updated their C4 Therapeutics ownership, watch for details on their new stake.**

AI Summary

Soleus Capital Master Fund, L.P. filed an amended SC 13G/A on February 2, 2024, indicating a change in their beneficial ownership of C4 Therapeutics, Inc. common stock as of December 31, 2023. This filing, an Amendment No. 1, updates their previous disclosure regarding their stake in the biotechnology company. This matters to investors because significant changes in institutional ownership can signal shifts in confidence or strategy, potentially influencing stock price movements.

Why It Matters

Changes in institutional ownership can signal a shift in a major investor's confidence in C4 Therapeutics, potentially impacting market perception and stock valuation.

Risk Assessment

Risk Level: medium — While an amendment itself isn't inherently risky, the underlying change in ownership could indicate a significant buy or sell, which carries market risk.

Analyst Insight

An investor should look for the specific details within the full filing to understand the change in Soleus Capital's ownership percentage and whether it represents an increase or decrease, which could inform their own investment decisions regarding C4 Therapeutics.

Key Players & Entities

• Soleus Capital Master Fund, L.P. (company) — the reporting person filing the SC 13G/A
• C4 Therapeutics, Inc. (company) — the subject company whose securities are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• February 2, 2024 (date) — the filing date of the SC 13G/A
• Cayman Islands (company) — place of organization for Soleus Capital Master Fund, L.P.

FAQ

Key Financial Figures

• $0.0001 — INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o

Filing Documents

• ea192410-13ga1soleus_c4thera.htm (SC 13G/A) — 95KB
• 0001213900-24-009358.txt ( ) — 97KB

Ownership

Item 4. Ownership. Reference is made to Items 5 – 11 on the preceding pages of this Schedule 13G. Master Fund held, as of the close of business on December 31, 2023, an aggregate of 1,835,996 shares of the common stock of the Issuer. As the general partner of Master Fund, Soleus Capital, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole managing member of Soleus Capital, LLC, Soleus Capital Group, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole managing member of Soleus Capital Group, LLC, Mr. Guy Levy may be deemed to have shared power to vote or direct the vote and to dispose or to direct the disposition of the Shares held by Master Fund. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission that Mr. Levy, Soleus Capital, LLC or Soleus Capital Group, LLC is the beneficial owner of the shares of the common stock of the Issuer referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose, and such beneficial ownership is expressly disclaimed, except to the extent of their respective pecuniary interests therein. 7

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following .

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose, or with the effect, of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: February 2, 2024 Soleus Capital Master Fund, L.P. By: Soleus Capital, LLC, its General Partner By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 Soleus Capital, LLC By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 Soleus Capital Group, LLC By: /s/ Guy Levy Name: G uy Levy Title: M anaging Member Date: February 2, 2024 /s/ Guy Levy Name: Guy Levy Footnotes: Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) 9 EXHIBIT A JOINT FILING AGREEMENT Soleus Capital Master Fund, L.P., a Cayman Islands exempted limited partnership, Soleus Capital, LLC, a Delaware limited liability company, Soleus Capital Group, LLC, a Delaware limited liability company, and Guy Levy, an individual, hereby agree to file jointly the statement on Schedule 13G to which this Joint Filing Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934, as amended. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the i

View Full Filing

View this SC 13G/A filing on SEC EDGAR